The VALID‐CRT risk score reliably predicts response and outcome of cardiac resynchronization therapy in a real‐world population-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The VALID‐CRT risk score reliably predicts response and outcome of cardiac resynchronization therapy in a real‐world population

Published:2019-07-13 Issue:10 Volume:42 Page:919-924
ISSN:0160-9289
Container-title:Clinical Cardiology
language:en
Short-container-title:Clin Cardiol

Author:

Bertaglia Emanuele¹,Arena Giuseppe²,Pecora Domenico³,Reggiani Albino⁴,D'Onofrio Antonio⁵,Palmisano Pietro⁶,De Simone Antonio⁷,Caico Salvatore I.⁸,Marini Massimiliano⁹^ORCID,Maglia Giampiero¹⁰,Ferraro Anna¹¹,Solimene Francesco¹²,Cecchetto Antonella¹³,Malacrida Maurizio¹⁴^ORCID,Botto Giovanni L.¹⁵,Lunati Maurizio¹⁶,Stabile Giuseppe¹⁷

Affiliation:

1. Department of Cardiac, Thoracic, and Vascular SciencesUniversity of Padova Padua Italy

2. Department of CardiologyApuane Hospital Massa Italy

3. Fondazione Poliambulanza Brescia Italy

4. Pieve di Coriano Hospital Pieve di Coriano (MN) Italy

5. Department of CardiologyMonaldi Hospital Naples Italy

6. Cardiology Unit'Card. G. Panico' Hospital Tricase (LE) Italy

7. San Michele Clinic Maddaloni (CE) Italy

8. Sant'Antonio Abate Hospital Gallarate (VA) Italy

9. Department of CardiologySanta Chiara Hospital Trento Italy

10. Pugliese‐Ciaccio Hospital Catanzaro Italy

11. Degli Infermi Hospital Rivoli (TO) Italy

12. Montevergine Clinic Mercogliano (AV) Italy

13. San Bortolo Hospital Vicenza Italy

14. Boston Scientific Milan Italy

15. U.O. ElectrophysiologyASST Rhodense Rho‐Garbagnate Milanese (MI) Italy

16. Cardiotoracovascular DepartmentASST Grande Ospedale Metropolitano Niguarda Milan Italy

17. Mediterranean Clinic Naples Italy

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/clc.23229

Reference16 articles.

1. Cardiac-Resynchronization Therapy with or without an Implantable Defibrillator in Advanced Chronic Heart Failure

2. The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart Failure

3. Cardiac-Resynchronization Therapy for Mild-to-Moderate Heart Failure

4. Morbidity and mortality in heart failure patients treated with cardiac resynchronization therapy: influence of pre-implantation characteristics on long-term outcome

5. The European CRT Survey: 1 year (9-15 months) follow-up results

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of sacubitril/valsartan and gliflozins on cardiac resynchronization therapy response in ischemic and non-ischemic heart failure patients;International Journal of Cardiology;2023-12

2. Risk Factors for Short-Term Versus Long-Term Mortality in Patients Who Underwent Cardiac Resynchronization Therapy;The American Journal of Cardiology;2023-06

3. The Role of Sacubitril/Valsartan and Gliflozins in Heart Failure with Reduced Ejection Fraction after Cardiac Resynchronization Therapy;2023-03-31

4. Prognostic value of non‐alcoholic fatty liver disease fibrosis score in patients undergoing cardiac resynchronization therapy;Pacing and Clinical Electrophysiology;2023-01-11

5. Feasibility and safety of left bundle branch area pacing—cardiac resynchronization therapy in elderly patients;Journal of Interventional Cardiac Electrophysiology;2022-03-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3